Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Light activated doxorubicin - POP Biotechnologies

Next Previous
Search
Drug Profile

Light activated doxorubicin - POP Biotechnologies

Alternative Names: Doxorubicin/Porphyrin phospholipid nanoparticles - POP Biotechnologies; NP 01 - POP Biotechnologies; NP-01 - Biotechnologies; Photo activated doxorubicin; PhotoDOX; PoP nanoparticles; PoP-liposome drug delivery system; Porphyrin-phospholipid nanoparticles - POP Biotechnologies

Latest Information Update: 28 Jun 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator POP Biotechnologies
  • Class Anthracyclines; Antineoplastics; Cytostatic antibiotics; Diagnostic agents; Doxorubicins; Porphyrins; Small molecules
  • Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Solid tumours

Most Recent Events

  • 28 Jun 2023 No recent reports of development identified for preclinical development in Solid-tumours in USA (IV)
  • 28 May 2019 Preclinical trials in Solid tumours in USA (IV) before May 2019 (POP Biotechnologies Pipeline, May 2019)
  • 28 May 2019 Pharmacodynamics data from preclinical trials in Solid tumours were released by POP Biotechnologies (POP Biotechnologies website, May 2019)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top